Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities

Fig. 1

Types of remote assessment: development and readiness for use. Outcomes are presented from left to right based on stage of development for remote use (Not Developed, Early Development, Late Development, and Ready for Use) and type of assessment (Patient-Reported = dark blue, Clinician Administered = light blue, Digital Biomarker = white). AROM = active range of motion; PROM = passive range of motion; MRC = medical research council; PRO = patient-reported outcome measure)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172